In the United States, ovarian cancer is the fifth most common cause of cancer related death. Recent evidence has shown that inflammation plays a role in the development ovarian cancer. It is believed that aspirin lowers ovarian cancer risk by reducing inflammation.
Many decades of research have provided strong evidence that the anti-inflammatory properties of aspirin may reduce cancer risk, particularly for colorectal cancer, and may benefit patients with high cardiovascular risk.
In regards to aspirin and ovarian cancer, the results were conclusive, however it was puzzling in that low doses of aspirin showed a decrease risk and higher doses showed an increased risk.
Per Dr. Obron “I don’t think we’re quite at the stage where I can recommend daily aspirin to lower ovarian cancer risk. We need more research but it’s definitely something that women should discuss with her physicians. Further research is ongoing and hopefully will clarify this issue”
These results highlight the importance of ongoing conversations between patients and doctors on the risks and benefits of taking low-dose aspirin.
Symptoms of ovarian cancer include bloating, pelvic or abdominal pain, in urinary symptoms such as urgency or frequency.